Acupuncture in Multiple Sclerosis

Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-58yq52

Enrollment

Unknown

Registered

2012-04-16

Start date

2011-01-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of life in Relapsing-Remitting Multiple Sclerosis

Interventions

the study had two groups: 1.eletroacupuncture true (n=16) 2.eletroacupuncture sham (n=15). The protocol consisted of 30 minutes of acupuncture (either true or sham electroacupuncture) once a week fo

other

H02.004

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a confirmed diagnosis of RRMS according to the revised 2005 McDonald criteria and under treatment with immunomodulatory drugs (interferon-beta and glatiramer acetate) were selected.

Exclusion criteria

Exclusion criteria: Those individuals who had previously received acupuncture treatment were excluded.

Design outcomes

Primary

Measure	Time frame
Clinical status, especially mobility, was assessed prior to the treatment, as well as after six months, using the Expanded Disability Status Scale (EDSS). Quality of life was also assessed prior to the initiation of treatment, as well as after three and six months; It was measured by the Functional Assessment of Multiple Sclerosis (FAMS) instrument, validated for Portuguese as (DEFU). Briefly, this is self-report questionnaire investigating patient perception of the quality of their lives, The six sub-scales assess mobility, symptoms, emotional well being/depression, general contentment, thinking/fatigue, and family/social well being, using a 5-point Likert-type scale ranging from “not at all” to “very much”, which yields a score between 0 (for not at all) and 4 (for very much) for each of the items. Pain was evaluated using the 10-point Visual Analogue Scale (VAS), 0= Worst possible pain and 10= No pain, applied just before the FAMS.	—

Measure

Time frame

Clinical status, especially mobility, was assessed prior to the treatment, as well as after six months, using the Expanded Disability Status Scale (EDSS). Quality of life was also assessed prior to the initiation of treatment, as well as after three and six months; It was measured by the Functional Assessment of Multiple Sclerosis (FAMS) instrument, validated for Portuguese as (DEFU). Briefly, this is self-report questionnaire investigating patient perception of the quality of their lives, The six sub-scales assess mobility, symptoms, emotional well being/depression, general contentment, thinking/fatigue, and family/social well being, using a 5-point Likert-type scale ranging from “not at all” to “very much”, which yields a score between 0 (for not at all) and 4 (for very much) for each of the items. Pain was evaluated using the 10-point Visual Analogue Scale (VAS), 0= Worst possible pain and 10= No pain, applied just before the FAMS.

—

Secondary

Measure	Time frame
Occasionally, patients reported improvement in spasticity, sleep and bowel function.	—

Countries

Brazil

Contacts

Public ContactJuan Quispe-Cabanillas

Departamento de Clinica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas - UNICAMP

juangqc@fcm.unicamp.br(19)35216263

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 25, 2026

Acupuncture in Multiple Sclerosis

Conditions

Related papers

Interventions

Sponsors

Eligibility

Inclusion criteria

Exclusion criteria

Design outcomes

Primary

Secondary

Countries

Contacts

Outcome results